Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$93.41 -1.80 (-1.90%)
At close: Oct 1, 2026 · 4:00 PM EDT

Rhythm Pharmaceuticals (RYTM) Return on Equity [ROE] (2017 - 2026)

Updated

Rhythm Pharmaceuticals (RYTM) reported Return on Equity [ROE] of -181.81% for Q2 2026, up 5020.15 percentage points from -5201.96% a year earlier but down 27.08 percentage points from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Return on Equity [ROE] (2017 - 2026) Analysis & Trends

For FY2025, Rhythm Pharmaceuticals posted Return on Equity [ROE] of -244.45%, up 27.73 percentage points from FY2024.

  • Return on Equity [ROE] has a five-year change of -184.57 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at -272.19% in FY2024 (-187.09 pp), -85.10% in FY2023 (-19.05 pp), -66.05% in FY2022 (-35.16 pp) and -30.89% in FY2021 (+28.99 pp).
  • Five-year quarterly Return on Equity [ROE] spans a low of -5201.96% in Q2 2025 and a high of -15.92% in Q3 2021.
  • Year over year, Return on Equity [ROE] has now increased in each of the last four quarters, with an average year-over-year change of +24.39 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q2 2026 (a gain of 5020.15 percentage points); the low point was Q2 2025 (a drop of 4687.81 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -154.73% (Q1 2026), -136.55% (Q4 2025) and -280.98% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Rhythm Pharmaceuticals 6.55 Bn 5.42 Bn 62.32 Mn -181.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -181.81%
Mar 31, 2026 -154.73%
Dec 31, 2025 -136.55%
Sep 30, 2025 -280.98%
Jun 30, 2025 -5,201.96%
Mar 31, 2025 -829.64%
Dec 31, 2024 -1,582.00%
Sep 30, 2024 -1,024.28%
Jun 30, 2024 -514.15%
Mar 31, 2024 -236.77%
Dec 31, 2023 -100.58%
Sep 30, 2023 -97.71%
Jun 30, 2023 -90.65%
Mar 31, 2023 -74.60%
Dec 31, 2022 -66.41%
Sep 30, 2022 -79.48%
Jun 30, 2022 -89.35%
Mar 31, 2022 -72.37%
Dec 31, 2021 -22.96%
Sep 30, 2021 -15.92%
API Access

Rhythm Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RYTM&period=max&api_key=YOUR_API_KEY